Biotricity Launches Direct-to-Consumer Heart Health Screening Service, HeartSecure, Making Heart Health Services Accessible in Response to the #1 Global Killer, Poising Company to Access the Growing Home Diagnostics Market

June 12, 2024 9:15 AM

Biotricity Inc. (NASDAQ:BTCY), a forerunning Technology-as-a-Service (TaaS) company committed to disrupting the healthcare industry with cutting-edge medical and consumer diagnostic solutions, today announces the highly anticipated launch of its direct-to-consumer heart health screening program, HeartSecure. Someone in the world dies of cardiovascular disease (CVD) every 1.5 seconds. In the U.S. alone, 127 million adults have at least 1 risk...

Read more

How Luciana Preger Is Helping Advance Gilead’s Work in Oncology

June 12, 2024 9:00 AM

NORTHAMPTON, MA / ACCESSWIRE / June 12, 2024 / Gilead SciencesLuciana Preger credits being exposed to her father's work at a young age with helping inform her own career in medicine. Luciana is a physician with more than 20 years of experience in pharma and she came to Gilead to help transform treatments for people living with cancer."As a child, I loved the opportunity to go on rounds with my father at the hospital in Rio de Janeiro and witness...

Read more

Nava Health Begins Construction on First Boston-Area Location; New Center in Chestnut Hill Will Provide Personalized Functional and Longevity Medicine

June 12, 2024 8:45 AM

Nava Health, a leader in longevity, integrative, and functional medicine, is pleased to announce it has begun construction on its first center in the Boston area, to be located in Chestnut Hill, at the popular luxury shopping destination, The Street at Chestnut Hill. The 4,252 square foot space will occupy 33 Boylston Street, offering residents of Chestnut Hill and surrounding areas access to Nava Health's innovative approach to personalized...

Read more

Jaguar Health to Report Pivotal Phase 3 OnTarget Trial Results for its Cancer Supportive Care Drug Crofelemer on or Before July 23, 2024

June 12, 2024 8:30 AM

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") today announced that it will hold an investor webcast on or before July 23, 2024 to provide results for the company's pivotal phase 3 OnTarget trial of crofelemer for prophylaxis of diarrhea in adult cancer patients with solid tumors receiving targeted therapy, with or without standard chemotherapy. The webcast, which will provide updates on Jaguar's advancing cancer supportive care portfolio, will...

Read more

Clearstep Unveils Advanced Self-Service Booking for Specialist Care

June 12, 2024 7:41 AM

Clearstep, in collaboration with a major New York health system, proudly announces the launch of its groundbreaking Sub-Specialist Qualification and Scheduling feature. This pioneering feature is the first in the U.S. to integrate a specialist scheduling decision tree, typically used by human call center agents, into an automated, self-service workflow that starts with triage.The new Clearstep feature is a thorough system designed to guide...

Read more

Rutherrin(R) Increases Efficacy of Chemotherapy

June 12, 2024 7:00 AM

Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated small molecules and their formulations intended for the safe and effective destruction of various cancers, bacteria and viruses, is pleased to announce that in preclinical research, it's lead drug formulation, Rutherrin® has been proven...

Read more

Biophytis Announces the Successful Industrial Transfer of BIO101 (20-hydroxyecdysone) Production by its Service Provider Seqens

June 12, 2024 4:25 AM

Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in the development of therapeutics for age-related diseases, announces the successful transfer of BIO101 (20-hydroxyecdysone) production to industrial scale by Seqens.Seqens, an integrated global player in solutions and ingredients for the pharmaceutical and speciality markets, offering a broad portfolio of active...

Read more

MindBio Therapeutics Reports Secondary Data: Improvement of Psychological Outcomes & Safety Results in Depressed Patients from Phase 2A Depression Trial

June 12, 2024 4:20 AM

MindBio Therapeutics Corp. (CSE:MBIO)(Frankfurt:WF6), (the "Company" or "MindBio"), a leading biopharmaceutical company in psychiatric medicine development using microdoses of psychedelic medicines, is delighted to report positive secondary data from its world-first take-home microdosing depression trial using MB22001 completed earlier this year. Data from MindBio's Phase 2A Depression trial indicates improvements in a range of secondary...

Read more

Waters | Wyatt Technology Forms a Strategic Collaboration With Bioz to Promote Scientific Discovery by Leveraging Publications

June 12, 2024 4:00 AM

PALO ALTO, CA / ACCESSWIRE / June 12, 2024 / Bioz, Inc., a cutting-edge AI software company that is deeply invested in facilitating research capabilities, is pleased to announce its recent partnership with the Waters | Wyatt Technology group, a recognized leader in the light scattering instrumentation space.Bioz Pro Badge Bioz Pro Badge on the Waters | Wyatt Technology Website In this exciting collaboration, BiozTM Badges, digital web-based...

Read more

Evotec Announces Progress in Neuroscience Collaboration with Bristol Myers Squibb

June 12, 2024 1:50 AM

Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) announced today that the Company has reached important scientific progress within its neuroscience collaboration with Bristol Myers Squibb (NYSE:BMY) triggering a research payment of US$ 20 m to Evotec. A target-based programme progresses into late pre-clinical development, further contributing to the fast-growing and promising pipeline of discovery to...

Read more

Gulf Coast Regional Blood Center Chooses the HemoFlow 500 and HemoVue Cloud Service to Upgrade Its Whole Blood Collection Operations

June 11, 2024 9:15 PM

GRASS VALLEY, CA / ACCESSWIRE / June 11, 2024 / Applied Science, the worldwide leader in whole blood collection products and services, today announced that Gulf Coast Regional Blood Center has purchased ASI's next-generation device, the HemoFlow 500, and HemoVue, its recently introduced cloud-based service that works with HemoFlow devices to provide real-time operational data and analytics that significantly improve blood collection and related...

Read more

Between Us Clinic Survey Reveals Urologists' Top Alternative ED Treatment Recommendations

June 11, 2024 1:00 PM

A new survey of 33 leading urologists aims to guide men through the often confusing landscape of erectile dysfunction (ED) treatments, separating evidence-based alternative therapies from misleading marketing claims.The survey, conducted by Between Us Clinic, a leading provider of online men's health resources, emphasizes that while some alternative treatments lack scientific backing, others can be valuable tools for managing ED, often in...

Read more

San Diego-Based Shoreline Recovery Center Provides Addiction Awareness, Mental Health Resources Through Community Education

June 11, 2024 1:00 PM

SAN DIEGO, CA / ACCESSWIRE / June 11, 2024 / For those afflicted by substance abuse and mental illness, it's important that intentional strategies are put into place to avoid relapse and additional episodes. This is done in part by removing the stigma itself by offering understanding and support to those who are seeking help. It includes compassionate treatment and access to resources so affected individuals can find hope and begin their journey...

Read more

Uniphar Logistics Backing SkyCell on Their Journey Towards Net-zero.

June 11, 2024 11:00 AM

Sky Cell AG, founded in Switzerland, continues paving the way for sustainable Pharma Logistics. With an industry-leading temperature excursion rate of less than 0.05%, their hybrid container solutions set a whole new standard for excellence.Their hybrid containers (pictured below), maintain inner temperatures for up to 270 hours, all while prioritizing sustainability. Head over to the SkyCell website to learn about their progress towards...

Read more

Fox Valley Hands of Hope and Mental Health Technologies Announce Partnership

June 11, 2024 11:00 AM

Providing clients with better care by tracking progress over time with MHT's patented technology, SmarTest™.AURORA, IL / ACCESSWIRE / June 11, 2024 / Fox Valley Hands of Hope is excited to announce a partnership with Mental Health Technologies to simplify the screening process for our clinicians and clients. Fox Valley Hands of Hope (FVHH) is a non-profit organization dedicated to providing support to children, adults, and families experiencing...

Read more

AlayaCare Selected by The Medical Team as Key Technology Partner for Integrated Healthcare Solutions

June 11, 2024 10:03 AM

The Medical Team, Inc., a trusted healthcare provider since 1978, has partnered with AlayaCare, a leading home-based care technology platform. With 21 locations across multiple states, The Medical Team is committed to delivering high-quality, cost-effective healthcare services. Through this collaboration, the company aims to enhance patient care and remain a provider of choice within its communities. "Our business, while not complex, becomes...

Read more

Rene's Naturals Unveils Essiac Superfood(R) for Immune Support Endorsed by Donovan McNabb

June 11, 2024 10:00 AM

Rene's Naturals, a leader in all-natural health solutions, is excited to announce the launch of its latest innovation, Essiac SuperFood® for immune support. This groundbreaking natural red and green superfood is meticulously formulated to promote optimal health through effective detoxification. Combining 12 organic greens, concentrated antioxidants, and a blend of prebiotics and probiotics, Essiac SuperFood® offers exceptional immune support and...

Read more

Kyle Neese Joins ACU-Serve as Senior Account Executive

June 11, 2024 10:00 AM

AKRON, OH / ACCESSWIRE / June 11, 2024 / ACU-Serve, a leading provider of healthcare management solutions, proudly announces the addition of Kyle Neese as Senior Account Executive. With over eight years of experience in the respiratory care industry, Neese brings a wealth of expertise and a passion for fostering client partnerships to his new role.Kyle Neese Before joining ACU-Serve, Neese dedicated his career to driving PAP ReSupply growth for...

Read more

STR Behavioral Health Opens Primary Mental Health Services at Silver Pines as a Dually Licensed Facility in Pennsylvania

June 11, 2024 9:30 AM

BRENTWOOD, TN / ACCESSWIRE / June 11, 2024 / Odyssey Behavioral Healthcare, a leading provider of addiction, mental health, and eating disorder treatment, is proud to announce that STR Behavioral Health is expanding access to mental health services with its Silver Pines location becoming dually licensed to treat primary mental health and substance use disorders. Silver Pines has a strong reputation for expertise in primary addiction treatment...

Read more

Alto Capital Announces New SPV Fund Into Cohesys, an Early Stage Medtech Startup in the Orthopedic Surgery Market

June 11, 2024 9:15 AM

Alto, an alternative asset platform that enables individuals to invest in alternative assets using both retirement and non-retirement funds, has announced the launch of the Cohesys SPV through Alto Capital, a wholly-owned subsidiary. The Cohesys SPV will be listed on Alto Marketplace, offering accredited investors a distinctive early-stage investment opportunity."It is an exciting partnership to raise capital for Cohesys, as they have identified...

Read more